CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +20,000 | $7.27 | $145K | 363,026 |
| 2020-09-16 | Hessekiel Jeffrey EVP and General Counsel | Sale | −20,000 | $26.11 | $522K | 343,026 |
| 2020-09-16 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −20,000 | 110,000 | ||
| 2020-09-15 | Senner Christopher J. EVP and CFO | Exercise or conversion | +20,000 | $3.66 | $73K | 147,882 |
| 2020-09-15 | Senner Christopher J. EVP and CFO | Sale | −20,000 | $25.00 | $500K | 127,882 |
| 2020-09-15 | Senner Christopher J. EVP and CFO | Exercise or conversion · Option (right to buy) | −20,000 | 130,000 | ||
| 2020-09-08 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +59,692 | $1.90 | $113K | 313,692 |
| 2020-09-08 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +190,000 | $6.21 | $1.2M | 503,692 |
| 2020-09-08 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −160,666 | $20.71 | $3.3M | 343,026 |
| 2020-09-08 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −59,692 | 20,000 | ||
| 2020-09-08 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −190,000 | 0 | ||
| 2020-09-02 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +9,370 | 135,901 | ||
| 2020-09-02 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,323 | $21.58 | $50K | 133,578 |
| 2020-09-02 | Haley Patrick J. EVP, Commercial | Grant or award | +4,498 | 116,687 | ||
| 2020-09-02 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −1,116 | $21.58 | $24K | 115,571 |
| 2020-09-02 | Hessekiel Jeffrey EVP and General Counsel | Grant or award | +4,998 | 255,311 | ||
| 2020-09-02 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −1,311 | $21.58 | $28K | 254,000 |
| 2020-09-02 | Senner Christopher J. EVP and CFO | Grant or award | +9,745 | 130,448 | ||
| 2020-09-02 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −2,566 | $21.58 | $55K | 127,882 |
| 2020-09-02 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Grant or award | +9,745 | 335,708 |
Page 41 of 42 · 836 trades